NCT01587651 - Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease | Biotech Hunter

Enrollment

110

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions

Coronary Artery Disease

Interventions

DRUG

Prasugrel Loading Dose

60mg given as six 10mg film coated tablets

DRUG

Prasugrel Maintenance Dose

10mg maintenance dose, given as one 10mg film coated tablet

DRUG

Ticagrelor Maintenance Dose

one 90mg film coated tablet

Trial Locations (13)

21215

Sinai Center for Thrombosis Research, Baltimore

32127

Progressive Medical Research, Port Orange

32209

Univ. of Florida College Medicine, Jacksonville

33014

Clinical Pharmacology Unit of Miami, Miami

45212

Medpace Clinical Pharmacology Unit, Cincinnati

57701

Black Hills Cardiovascular Research, Rapid City

77094

West Houston Area Clinical Trial Consultants, Houston

77450

Cardiology Center of Houston, Katy

CF14 4XW

University Hospital of Wales, Heathpark

B52 8HW

Bristol Heart Institute, Bristol

LE3 9QP

University Hospital Leicester, Leicester

SO16 6YD

Southampton General Hospital, Southampton

WV10 0QP

New Cross Hospital, Wolverhampton